Stocks & Investing
Stocks and Investing
Stocks and Investing
Mon, April 17, 2023
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Sun, April 16, 2023
[ 12:00 AM ] - United States, WOPRAI
Fri, April 14, 2023
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Tazeen Ahmad Maintained (SRPT) at Strong Buy and Held Target at $164 on, Apr 14th, 2023
Tazeen Ahmad of B of A Securities, Maintained "Sarepta Therapeutics, Inc." (SRPT) at Strong Buy and Held Target at $164 on, Apr 14th, 2023.
Tazeen has made no other calls on SRPT in the last 4 months.
There are 14 other peers that have a rating on SRPT. Out of the 14 peers that are also analyzing SRPT, 1 agrees with Tazeen's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Judah Frommer of "Credit Suisse" Maintained at Hold with Decreased Target to $139 on, Friday, March 17th, 2023
These are the ratings of the 13 analyists that currently disagree with Tazeen
- Gavin Clark-Gartner of "Evercore ISI Group" Maintained at Buy and Held Target at $149 on, Thursday, April 13th, 2023
- Neena Bitritto-Garg of "Citigroup" Initiated at Strong Buy and Held Target at $179 on, Tuesday, April 4th, 2023
- Ritu Baral of "TD Cowen" Maintained at Buy with Increased Target to $175 on, Wednesday, March 22nd, 2023
- Gil Blum of "Needham" Maintained at Strong Buy with Decreased Target to $160 on, Friday, March 17th, 2023
- Brian Abrahams of "RBC Capital" Maintained at Buy with Decreased Target to $200 on, Friday, March 17th, 2023
- Hartaj Singh of "Oppenheimer" Maintained at Buy with Decreased Target to $150 on, Thursday, March 9th, 2023
- Anupam Rama of "JP Morgan" Maintained at Buy with Increased Target to $206 on, Friday, March 3rd, 2023
- Salveen Richter of "Goldman Sachs" Maintained at Strong Buy with Increased Target to $190 on, Wednesday, March 1st, 2023
- Matthew Harrison of "Morgan Stanley" Upgraded from Hold to Buy and Increased Target to $187 on, Wednesday, March 1st, 2023
- Brian Skorney of "Baird" Maintained at Buy with Increased Target to $202 on, Wednesday, March 1st, 2023
- Joseph Schwartz of "SVB Leerink" Reiterated at Buy and Held Target at $160 on, Friday, January 20th, 2023
- Yun Zhong of "BTIG" Maintained at Strong Buy with Increased Target to $160 on, Thursday, December 22nd, 2022
- Colin Bristow of "UBS" Upgraded from Hold to Strong Buy and Increased Target to $158 on, Friday, December 16th, 2022
